Picture of Larimar Therapeutics logo

LRMR — Larimar Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Larimar Therapeutics Q2 Net Income USD -8.366 Million

Aug 10 (Reuters) - Larimar Therapeutics Q2 operating expenses USD 9.62
million.
* Q2 income from operations USD -9.62 million
* Q2 basic EPS USD -0.19

Recent news on Larimar Therapeutics

See all news